Skip to main content
OpenTrials
Completed

NCT Number: NCT03234621

Protective Ventilation Strategy

The purpose of this study is to find a proper ventilation strategy for one-lung ventilation to prevent postoperative pulmonary complications

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing elective thoracic surgery
  • ASA I, II, III
  • scheduled > 2 hours of surgery

Exclusion criteria

  • denied patients
  • age under 18 years
  • FEV1/FVC or FEV1<70% in preoperative pulmonary function test

Treatment and study plan

ventilator setting during one-lung ventilation

Other

providing various tidal volumes according to the groups with constant PEEP

Primary outcomes

  1. postoperative pulmonary complications

    Time frame: immediately after operation

    PaO2/FiO2 and/or newly appeared atelectasis, lung infiltration

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Protective Ventilation Strategy During One-lung Ventilation: Effect on Postoperative Pulmonary Complications

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jul 31, 2017
Registry last updated
Apr 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.